Navigation Links
Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
Date:3/15/2011

urrent treatments results in high treatment and post-treatment costs to the medical system."

The electroporation technology being sold and licensed to OncoSec is based on Inovio's industry-leading electroporation technology platform that, in addition to DNA vaccines and immune therapeutics, can also be used to efficiently deliver a chemotherapeutic or cytokine agent for the treatment of cancer. When these chemotherapeutic or cytokine agents are injected into a selected treatment area such as a tumor and the predominantly healthy tissue in the margin surrounding a tumor, they have been shown to selectively and quickly destroy the tumor and cancer cells in the tumor margin. The chemotherapeutic agent acts by directly killing cancerous cells at the delivery site. Cytokine agents act by inducing broad, non-antigen specific immune responses that have been shown to kill cancerous cells. These therapies enable heightened concentrations of medicine to be directed to the cancer while reducing overall dosage and moderating or eliminating side effects associated with systemically-applied therapeutic approaches. This optimized delivery is enabled by Inovio's proprietary electroporation process, which locally applies brief controlled electrical pulses to cells to temporarily and reversibly increase permeability of the cell membranes in selected tissue and dramatically increase cellular uptake of the previously injected agent as seen in previous animal studies and earlier human clinical trials.

About OncoSec Medical Inc.OncoSec (OTC BB: ONCS.D), based in San Diego, California, designs, develops and commercializes innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs or where currently approved therapies are inadequate based on their efficacy level or side effect profile. The company's therapies are based on the use of electroporation delivery in combination with an approved chemotherapeutic drug or a cytokine agent to
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
6. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
7. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
8. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
9. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro ... Alliance (HITRUST) under its Common Security Framework (CSF). ... Security and Privacy Manager, "We appreciate this rigorous, ... of commitment that this certification signifies. Our business ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s internal ...
(Date:8/21/2014)... 21, 2014 BreedIT Corp., ... the exclusive worldwide license holder and distributor of ... and researchers, today is pleased to announce the ... Seach Ltd, a leading Israeli medical Cannabis breeder. ... develop new breeds of medical Cannabis to meet ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3ScriptPro Achieves HITRUST Certification 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4
... How Each Tooth Signals the Next to Start GrowingROCHESTER, ... forces determines why mammals develop a single row of ... published today in the journal Science. When completely understood, ... guide efforts to re-grow missing teeth and prevent cleft ...
... preventing bone loss focus on early screening and treatmentLAS ... 75 million baby boomers are approaching the age where ... Osteoporosis ( http://orthoinfo.aaos.org/topic.cfm?topic=A00232 ) also contributes ... United States annually. According to new information presented ...
Cached Medicine Technology:Scientists Discover Why Teeth Form in a Single Row 2Scientists Discover Why Teeth Form in a Single Row 3Scientists Discover Why Teeth Form in a Single Row 4Scientists Discover Why Teeth Form in a Single Row 5Staying One Step Ahead of Osteoporosis 2Staying One Step Ahead of Osteoporosis 3Staying One Step Ahead of Osteoporosis 4
(Date:8/21/2014)... The American College of Chest Physicians (CHEST) announces ... Ill and Injured During Pandemics and Disasters: CHEST ... of the journal CHEST while the ... Ebola virus. The consensus statement aims to guide ... research in crises. The statement was developed by ...
(Date:8/21/2014)... Hudson County, NJ (PRWEB) August 21, 2014 ... that two leading Radiologists, Amish P. Patel, MD, ... Department. Our system welcomes Dr. Patel and Dr. ... provides a comprehensive array of diagnostic imaging services ... resources of Bayonne Medical Center, Christ Hospital and ...
(Date:8/21/2014)... with schizophrenia often have trouble engaging in daily tasks ... from San Francisco State University suggests the reason might ... required to complete tasks. , The research, detailed in ... of Abnormal Psychology , can assist health professionals in ... those patients function normally by breaking up larger, complex ...
(Date:8/21/2014)... 2014 Greater awareness among parents and ... before they are full term has decreased the practice ... the country, early elective deliveries (EEDs) still occur too ... EED is defined as delivery before 39 weeks without ... morbidity and mortality, and offers no benefit to mothers ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Black Americans are ... racial groups battling the blood sugar disease, a new ... National Health and Nutrition Examination Survey, which evaluates about ... the highest rates of a condition known as diabetic ... blindness in people with diabetes. Diabetic macular edema ...
Breaking Medicine News(10 mins):Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:Difficulty assessing effort drives motivation deficits in schizophrenia, study finds 2Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 2Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 3Health News:Blacks May Face Higher Risk of Diabetes-Linked Vision Loss 2
... Authentidate Holding Corp. (Nasdaq: ADAT ), ... management services, today announced that it plans to report financial ... 2009 on Monday, November 16, 2009, after the close of ... Monday, November 16, 2009, at 4:30 p.m. ET, to discuss ...
... ... By Focusing On Each Person,s Spiritual Potential and How It Affects Relationships, Career and ... ... and president of Spiritual Personality, has just announced an innovative system to categorize personality. ...
... It is ... of help, unaware of their rights, if Yaz, the most popular birth control pill in the ... to women or the families of women who have suffered from serious health problems after taking ... St. Louis, MO (Vocus) November ...
... , INDIANAPOLIS, Nov. 12 Centerplate, the ... and sports stadiums, announced today with the Capital ... comprehensive investigation of Lucas Oil Stadium to immediately ... the facility operates as a model of operational ...
... (OTC Bulletin Board: VIVK) is the keynote presenting company ... International, Inc. ( www.regeneca.com ). The celebration ... of Regeneca International from across the United States. It ... in Newport Beach, California. Vivakor,s Chairman, Matt Nicosia ...
... Peak Performance Symposium will take place on November 16th ... Stazione Centrale), Milan Central Station. , http://www.mindroom.com/detailinside.php?id=1 ... the benefits that the application of Neuroscience Research can ... Business. Modern approaches of Neurofeedback and Biofeedback will be ...
Cached Medicine News:Health News:Authentidate Holding Corp. to Report Fiscal 2010 First Quarter Results on Monday, November 16, 2009 2Health News:Hawaii Psychiatrist Develops Radical New System of Understanding and Categorizing Personality 2Health News:Yaz and Yasmin Birth Control Lawsuits Continue to Mount,The Onder Law Firm Will Provide a Free Case Review to Women Suffering from Yaz Side Effects 2Health News:Yaz and Yasmin Birth Control Lawsuits Continue to Mount,The Onder Law Firm Will Provide a Free Case Review to Women Suffering from Yaz Side Effects 3Health News:Centerplate and the Capital Improvement Board Investigating Food Safety Violations at Lucas Oil Stadium to Ensure Highest Standards Achieved and Operational Excellence 2Health News:Vivakor Presents at Nutraceutical Event 2Health News:Vivakor Presents at Nutraceutical Event 3Health News:Vivakor Presents at Nutraceutical Event 4Health News:Vivakor Presents at Nutraceutical Event 5Health News:Vivakor Presents at Nutraceutical Event 6Health News:Peak Performance, Neurofeedback and Biofeedback: New Frontiers of Empowerment From, and In, Sport 2
... five classes of resectoscope electrodes for ... knife, roller bar & ball, and ... electrodes specifically integrated into the ACMI ... with minimal bleeding, increased visibility, and ...
... Pro System features a small diameter Percutaneous ... With a reduced outer diameter (11Fr.) and ... can be used as a nephroscope or ... an outer sheath (15.9Fr), it can be ...
ACMI™ S-Series Resectoscope Systems: Precision instruments designed for superior optical recognition, accurate control, and exceptional durability during steam autoclave sterilization....
... Rotating Continuous Flow Resectoscopes enhance ease of ... the working element and telescope to the ... result no rotating components in the ... rotating flow ports, simplifying procedures. The new ...
Medicine Products: